Related Experiment Video
Updated: Jul 29, 2026

10:02
A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Late effects of poliomyelitis.
Archives of Physical Medicine and Rehabilitation
|January 1, 1987
Summary
Postpolio muscular weakness often develops decades after polio, causing significant functional decline. This study defines its characteristics and impact on patients.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Epidemiology
Background:
- Poliomyelitis survivors often experience late-onset muscular atrophy and reduced functional capacity.
- Postpolio syndrome (PPS) is characterized by new or worsening muscle weakness, fatigue, and pain decades after the initial infection.
Purpose of the Study:
- To define the characteristics of late-onset postpolio muscular weakness, including age of onset, symptoms, and severity.
- To assess the potential benefits of environmental modifications, respiratory aids, and orthoses for individuals with postpolio muscular weakness.
Main Methods:
- A cohort of 183 postpolio patients underwent physician examination and completed a detailed questionnaire.
- Data collected included ambulatory status, musculoskeletal and respiratory symptoms, and history of polio and subsequent weakness onset.
Main Results:
- 154 patients reported late deterioration in strength, characterized by decreased endurance, limited ambulation, and weakness in previously affected limbs.
- Average age of polio onset was 8.3 years, with postpolio muscular weakness onset at 42.3 years after a 34.8-year stable period.
- Fasciculations (51%), fractures (21%), and sleep disturbances (31%) were common; weakness often presented as steplike decrements with plateaus.
Conclusions:
- Late-onset postpolio muscular weakness significantly impacts functional status and general health.
- The findings underscore the need for targeted interventions and support for polio survivors experiencing late-onset weakness.
Related Concept Videos
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

